Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Research To Practice | Oncology Videos · Jun 13, 2025 · 59m

Featuring perspectives from Prof Claire Harrison and Dr John Mascarenhas, including the following topics:

Introduction (0:00)

New Biology of Myelofibrosis (1:55)

Novel Regulatory T-Cell Infusion Therapy (14:57)

Myelofibrosis 2025: JAK Inhibitors (Ruxolitinib) (20:39)

BET Inhibitors: Pelabresib (42:03)

Navtemadlin (53:20)

CME information and select publications